已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study

医学 不良事件通用术语标准 低温消融 回顾性队列研究 阶段(地层学) 累积发病率 间质性肺病 四分位间距 肺癌 不利影响 危险系数 队列 外科 内科学 置信区间 烧蚀 古生物学 生物
作者
Jonathan A. Sänger,Alexander Graur,Ismail Tahir,Melissa C. Price,Florence K. Keane,Michael Lanuti,Amita Sharma,Florian J. Fintelmann
出处
期刊:Lung Cancer [Elsevier BV]
卷期号:181: 107231-107231 被引量:10
标识
DOI:10.1016/j.lungcan.2023.107231
摘要

To compare the safety and efficacy of cryoablation of treatment-naïve stage IA non-small cell lung cancer (NSCLC) in patients with and without interstitial lung disease (ILD).This retrospective single-center cohort study evaluated 33 consecutive patients (24 females, median age 75 years, Eastern Cooperative Oncology Group performance score 0-3) with ILD (9 patients) and without ILD (24 patients) who underwent 39 percutaneous cryoablations to treat 42 stage IA (8th IASLC edition) NSCLC measuring 1.2 cm (range 0.5-2.6 cm) from 2018 to 2022. Presence of ILD was determined according to 2018 American Thoracic Society Criteria on pre-ablation CT scans. The primary outcome was 90-day adverse events graded by the Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Secondary outcomes were hospital length of stay (LOS), local recurrence-free survival, overall survival, and the cumulative incidence of local recurrence with death as a competing risk.Adverse events ranged from grade 1-3 and occurred more often in the non-ILD group (p <.001). No acute exacerbation of ILD or death occurred within 90 days after cryoablation. The median LOS was 1 day (interquartile range 1-2 days) and did not differ between groups. One patient with ILD and two patients without ILD died after 22, 26, and 27 months from causes unrelated to cryoablation. Median imaging follow-up was 11 months (range, 0-47 months) and three tumors (7%) showed local recurrence after 4, 17, and 22 months. No difference in the cumulative incidence of local recurrence (p =.56) was found. Among all patients, local recurrence-free survival on a per-tumor basis and overall survival were 97% and 100% at 1 year, respectively.Adverse events and local recurrence following percutaneous cryoablation of stage IA NSCLC did not differ between patients with and without ILD. No acute exacerbation of ILD or death within 90 days were observed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
万能图书馆应助HongY采纳,获得10
刚刚
刚刚
Lidocaine完成签到,获得积分10
刚刚
希特勒发布了新的文献求助10
3秒前
5秒前
5秒前
1218完成签到 ,获得积分10
8秒前
13秒前
14秒前
苏和杨发布了新的文献求助10
16秒前
nicenice发布了新的文献求助10
16秒前
16秒前
17秒前
18秒前
万能图书馆应助称心嫣娆采纳,获得10
19秒前
20秒前
深情安青应助苏和杨采纳,获得10
21秒前
24秒前
田様应助orange9采纳,获得10
26秒前
完美世界应助然大宝采纳,获得10
27秒前
Arui发布了新的文献求助10
29秒前
30秒前
大模型应助丰富钢铁侠采纳,获得10
30秒前
31秒前
Zhanghh87发布了新的文献求助10
31秒前
32秒前
我是老大应助mellow采纳,获得10
35秒前
momo发布了新的文献求助10
35秒前
dabao应助不喜采纳,获得10
35秒前
贰鸟应助Muhammad采纳,获得10
36秒前
漂亮白枫发布了新的文献求助10
36秒前
39秒前
iNk应助Sky36001采纳,获得20
40秒前
龙金兴完成签到 ,获得积分10
40秒前
43秒前
LYSM应助shangjiaGuo采纳,获得30
44秒前
45秒前
45秒前
Akim应助科研通管家采纳,获得10
46秒前
科研通AI2S应助科研通管家采纳,获得10
46秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989797
求助须知:如何正确求助?哪些是违规求助? 3531914
关于积分的说明 11255516
捐赠科研通 3270597
什么是DOI,文献DOI怎么找? 1805008
邀请新用户注册赠送积分活动 882181
科研通“疑难数据库(出版商)”最低求助积分说明 809190